Syngenta Ag (SYT) 76.56 $SYT Is Syngenta (SYT) Stock

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Syngenta Ag (SYT) 76.56 $SYT

Is Syngenta (SYT) Stock Worth Adding to Your Portfolio?
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:46AM CDT
On Apr 13, 2016, Zacks Investment Research upgraded Syngenta AG (SYT) to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell).
BG: 60.21 (-0.25), SYT: 76.56 (+0.84), AG: 16.91 (+1.50), AGFS: 5.92 (-0.09)

Agricultural Chemicals Industry's Stocks Get Research Review
ACCESSWIRE - Fri Jun 10, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 10, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Agricultural Chemicals industry. Companies recently under review include E. I. du Pont de Nemours, Intrepid Potash, Syngenta, and Ceres. Register with us now for your free membership and see our complete reports on these equities at:
SYT: 76.56 (+0.84), CERE: 0.40 (+0.01), DD: 66.09 (+0.15), IPI: 1.35 (-0.02)

ETFs to Watch on Monsanto Buyout Offer
Sweta Killa - Zacks Investment Research - Tue May 24, 8:46AM CDT
The German chemical giant made all-cash bid to acquire Monsanto for $62 billion, including debt, putting these ETFs on spotlight.
XLB: 48.18 (+0.13), SYT: 76.56 (+0.84), MON: 101.13 (-1.20), MOO: 48.83 (+0.26), VEGI: 23.39 (+0.07), IYM: 79.40 (+0.20), DD: 66.09 (+0.15), DOW: 51.18 (+0.23)

Syngenta Down to Sell on Unfavorable Business Environment
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:45AM CDT
On May 19, 2016, Zacks Investment Research downgraded Syngenta AG (SYT) to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold).
SYT: 76.56 (+0.84), AG: 16.91 (+1.50), BHP: 30.91 (+0.07)

Company News for May 18, 2016
Zacks Equity Research - Zacks Investment Research - Wed May 18, 9:10AM CDT
Companies in the News are: ALK,VA,HTZ,ODP,SPLS,SYT
SPLS: 9.06 (-0.09), HTZ: 50.13 (-0.37), SYT: 76.56 (+0.84), VA: 56.08 (-0.08), ODP: 3.33 (-0.02), ALK: 63.17 (-0.08)

Nutritional Experts Laud Nutrient Rich & Naturally Harvested Ingredients such as Eco-Friendly Moringa; Company Enters JV to Meet Growing Moringa Demand
PR Newswire - Thu May 05, 7:30AM CDT
Nutrient rich & eco-friendly ingredients appear to not only be fuel for the human body, but also the agricultural sector as companies race to develop advancing, naturally harvested components. With new, JV projects, research and products being introduced daily, companies with current developments of note in the markets today are New Global Energy, Inc. (OTC: NGEY), Monsanto Company (NYSE: MON), Syngenta AG (NYSE: SYT) DuPont Co. (NYSE: DD) & Agrium Inc. (AGU).
SYT: 76.56 (+0.84), MON: 101.13 (-1.20), AGU: 92.87 (+1.61), DD: 66.09 (+0.15)

Syngenta Annual General Meeting
PR Newswire - Tue Apr 26, 7:30AM CDT
At the Annual General Meeting of Syngenta AG held on April 26, 2016, the 1337 shareholders representing 50.68% of the total shares approved all the motions proposed by the Board of Directors.
SYT: 76.56 (+0.84)

Look for Shares of Syngenta to Potentially Rebound after Yesterday's 1.21% Sell Off
Comtex SmarTrend(R) - Fri Apr 22, 1:34PM CDT
Syngenta (NYSE:SYT) traded in a range yesterday that spanned from a low of $82.08 to a high of $82.70. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $82.76 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SYT: 76.56 (+0.84)

BioControl Agents Market By Active Substance (Microbials, Macrobials,); By Application (Seed Treatment, On-Field); By Environment; By Crop (Cereals & Grains, Vegetables & Fruits); By Target Pest (Arthropods, Weeds, Micro-organisms) -Forecast (2015 - 2020)
PR Newswire - Thu Apr 21, 6:02PM CDT
BioControl Agents (BCAs) are beneficial organisms that assist farmers in pest control and plant growth. BCA is one of the emerging trends in the crop protection industry supporting the wider trend of non-chemical pest control. This market encompasses a wide variety of natural enemies which combat different pests in several crop fields. Providers of these products assist the growers in choosing and release of specific BioControl product. Increasing concern on soil fertility, environmental and food contamination related to excess use of chemical pesticides is one of the primary factors that have been driving the growth of this market. However, lack of enough awareness and knowledge among growers regarding these environmental friendly and effective pest control mechanisms hinders the reach of BioControl products. The global BCAs market has been analyzed with respect to different parameters such as demand, supply, end-users and providers of BCAs. BCAs market encompasses several types of organisms which differ in size and mode of action. On the basis of active substance, the report is segmented into Microbials, Macrobials, Entomopathogenic nematodes. Microbials are mostly preferred by the out-field growers due to their wide availability, lower cost and their potential to suppress various pests. Beneficial insects are provided in packages which are placed in the field to facilitate their release whereas, microbial products are offered in the form of liquid or granules that are typically distributed through standardized agricultural equipment. The overall market is also presented from the perspective of different geographic regions and the key countries in each region. North America is the dominant market which held more than one-third share in 2014 and is estimated to be the fastest growing, mainly driven by escalating preference among growers and increasing penetration of IPM practices in the agricultural system of this region. Currently, the BioControl Agents segment accounts to 3%-4% of the global pest control market. The global BCAs market is estimated to reach $2,871.6m by 2020 at a CAGR of 13.1%. On-field is the largest application for BCAs primarily driven by the use of beneficial insects, followed by seed treatment based on micro-organisms based on fungi and bacteria. BCAs market is dominated by five major companies, namely: Bayer CropScience AG, BASF SE (Germany), Syngenta AG (Switzerland), Novozymes A/S (Denmark) and Koppert Biological systems (Netherlands), all of these companies together held a major market share in 2014.These companies have significant presence in the BCAs market with wide product mix and considerable brand image. Other major players in this market include: Monsanto Company Inc. (U.S.), Biobest N.V. and Marrone BioInnovations Inc. (U.S.).
SYT: 76.56 (+0.84), MON: 101.13 (-1.20)

Syngenta Posts Lackluster Q1 Trading Results, Raises Outlook
Zacks Equity Research - Zacks Investment Research - Thu Apr 21, 10:13AM CDT
Premium agricultural chemicals company Syngenta AG (SYT) reported weak trading results for first-quarter 2016.
SYT: 76.56 (+0.84), EGO: 4.96 (+0.05), AGI: 9.94 (+0.13), APD: 147.92 (+0.22)

Sulphur Coated Urea Market: Global Industry Analysis 2015-2025 - Key Players are Agrium Inc., Harrell's LLC & Syngenta AG - Research and Markets
BusinessWire - Mon Apr 18, 8:00AM CDT
Research and Markets has announced the addition of the "Sulphur Coated Urea Market: Global Industry Analysis and Opportunity Assessment, 2015-2025" report to their offering.
SYT: 76.56 (+0.84)

Syngenta Downgraded to Hold on Agro-Industry Headwinds
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:45PM CDT
On Apr 13, 2016, Zacks Investment Research downgraded Syngenta AG (SYT) to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
SYT: 76.56 (+0.84), LMNR: 17.90 (-0.11), AU: 21.26 (+0.88), AGI: 9.94 (+0.13)

Monsanto (MON) Faces Macro Risks: Dump the Stock Now?
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 12:55PM CDT
On Apr 11, 2016, we issued an updated research report on premium agro-chemical firm Monsanto Company (MON).
MON: 101.13 (-1.20), SYT: 76.56 (+0.84), LMNR: 17.90 (-0.11), AGI: 9.94 (+0.13)

Monsanto Misses Q2 Earnings Estimates, Cuts FY16 Guidance
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 10:02AM CDT
Monsanto Company (MON) reported disappointing results for second-quarter fiscal 2016 (ended Feb 29, 2016).
MON: 101.13 (-1.20), SYT: 76.56 (+0.84), LMNR: 17.90 (-0.11), AGI: 9.94 (+0.13)

Syngenta (SYT) Poised to Grow Amid Headwinds: Buy Now?
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 12:45PM CDT
On Mar 14, 2016, we issued an updated research report on Syngenta AG (SYT).
FSM: 8.79 (+0.28), AUMN: 0.82 (+0.04), SYT: 76.56 (+0.84), ASM: 2.97 (+0.13)

Monsanto's New Deals to Widen Climate FieldView's Reach
Zacks Equity Research - Zacks Investment Research - Mon Mar 07, 12:20PM CST
Monsanto Company (MON) recently proclaimed that Climate Corporation has inked data connectivity agreements with many retailer and agronomic software systems.
AUMN: 0.82 (+0.04), MON: 101.13 (-1.20), SYT: 76.56 (+0.84), AU: 21.26 (+0.88)

3 Reasons Monsanto Stock Could Rise
Dan Caplinger, The Motley Fool - Motley Fool - Sun Mar 06, 6:20AM CST
Image: Monsanto. The past year has been a tough one for the agricultural industry, and Monsanto has seen its stock lose almost a quarter of its value since early 2015. Poor prices for commodity crops have taken their toll on demand from farmers,...
SYT: 76.56 (+0.84), MON: 101.13 (-1.20), DE: 82.96 (+0.54)

This FDA Test Could Devastate Monsanto Inc.
Rich Duprey, The Motley Fool - Motley Fool - Sat Mar 05, 6:50AM CST
The FDA will begin testing our food supply for traces of glyphosate, the active ingredient in Monsanto's Roundup herbicide. Image source: Horia Varlan . Uh-oh. This can't be good for Monsanto . As if the chemicals giant didn't have enough on its...
SYT: 76.56 (+0.84), MON: 101.13 (-1.20), CPB: 66.72 (+0.25), DOW: 51.18 (+0.23)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moore Law Urges Millrose Investors: Join the Action

Updated Category News Views 9

Is Millrose Playing a Risky Game? When I caught wind of this latest debacle with Millrose Properties, Inc. (NYSE: MRP), my gut reaction was a mix of curiosity and skepticism. Hunterbrook Media's report just blasted across the headlines, digging up some dirt on Millrose's recent financial maneuvers. Apparently, these cats have been busy buying homes to the tune of $200...

Continue Reading
TilePix Expands into Walmart with Nail-Free Decor Launch

Updated Category News Views 12

TilePix Makes Big Moves with Walmart TilePix is launching their new line of nail-free wall décor at Walmart—this ain’t your grandma’s wall art. This company's bringing their magnetic, nail-free wizardry to retail stores nationwide for the first time, and they’ve chosen a real heavyweight partner—Walmart. What comes in the package? Well, they’re dealing in...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 15

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 8

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
Roof Inspections: Richmond's Key to Home Longevity

Updated Category News Views 13

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 11

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 11

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 10

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
Ama La Vida's New Coaching: More Than a Financial Plan

Updated Category News Views 6

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Continue Reading
Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 6

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Focused on Mynaric AG Raises Investor Concerns

Updated Category News Views 211

Investigation into Mynaric AG Sparks Investor Alerts Pomerantz LLP is actively looking into claims on behalf of investors of Mynaric AG (NASDAQ: MYNA). This investigation aims to uncover whether there have been any instances of securities fraud or questionable business practices involving the firm and its management. Mynaric's Guidance Update Raises Red Flags In a recent...

Continue Reading
Atlantic American Corporation's Impressive Q3 Performance Revealed

Updated Category News Views 177

Strong Financial Performance in the Third Quarter Atlantic American Corporation (NASDAQ: AAME), based in Atlanta, has recently announced an impressive financial performance for the third quarter. The company reported net income of $0.6 million, or $0.02 per diluted share, for the three-month period ending in September. This is a noteworthy improvement compared to a net...

Continue Reading
Ford Motor Company's Recent Legal Challenges: What You Should Know

Updated Category News Views 134

Understanding the Recent Class Action Lawsuit Against Ford Motor Company Ford Motor Company, often referred to simply as Ford, has recently come under scrutiny due to a class action lawsuit alleging violations of securities laws. Investors who purchased shares of the company during the specified class period may be wondering about their rights and the potential...

Continue Reading
Exploring the Impact of Therapy Dogs on Student Wellness

Updated Category News Views 108

Exploring the Positive Effects of Therapy Dogs The Human Animal Bond Research Institute (HABRI) has initiated exciting new research focused on the effects of therapy dog interactions on heart and brain activity. This fascinating study, led by a team at the University of Wollongong, aims to delve deep into the benefits that these furry companions bring to student health...

Continue Reading
PayPoint's Strategic Share Buyback Program Updates

Updated Category News Views 175

Understanding PayPoint's Recent Share Buyback Transactions In a significant move reflecting its positive outlook, PayPoint plc has announced a pivotal purchase of ordinary shares. This initiative is part of a broader strategy to enhance shareholder value and strengthen the overall market presence of the company. Details of the Share Purchases The financial records reveal...

Continue Reading
a>